Other Gastrointestinal Diseases
Show Only Open Trials
1.
GS-US-321-0105: GS-6624 in the Treatment of Liver Fibrosis in Subjects With Advanced Liver Fibrosis But Not Cirrhosis Secondary to Non-Alcoholic Steatohepatitis (NASH)
- Study Status: Open to Enrollment
- Sponsor: Gilead
- Disease Status and/or Stage: Advanced Liver Fibrosis as a Result of NASH (non-lcoholic steatohepatitis)
2.
GS-US-321-0102: GS-6624 in the Prevention of Progression of Liver Fibrosis in Subjects With With Primary Sclerosing Cholangitis (PSC)
- Study Status: Open to Enrollment
- Sponsor: Gilead
- Disease Status and/or Stage: Primary Sclerosing Cholangtis (PSC)
- Protocol ID: GS-US-321-0102
